Rucaparib
Poly(ADP-Ribose) Polymerase Inhibitor
Brands
Rucaparib Oral Tablet
| Dosage | Brand | Image |
|---|---|---|
| rucaparib 200 MG Oral Tablet | Generic | |
| rucaparib 200 MG Oral Tablet [Rubraca] | Generic | |
| rucaparib 250 MG Oral Tablet | Generic | |
| rucaparib 250 MG Oral Tablet [Rubraca] | Generic | |
| rucaparib 300 MG Oral Tablet | Generic | |
| rucaparib 300 MG Oral Tablet [Rubraca] | Generic |
Rucaparib desired effects:
- Cellular Growth Phase Reduction
- Decreased Reverse Transcription to DNA
- Decreased DNA Integrity
Rucaparib drug classes:
- Poly(ADP-Ribose) Polymerase Inhibitor
Rucaparib pharmacologic actions:
- Poly(ADP-ribose) Polymerase Inhibitors
Rucaparib mechanism of action:
- Poly(ADP-Ribose) Polymerase Inhibitors
